StockCIK 1411690

Bionano Genomics, Inc. (BNGO): Insider Trades and Fund Holdings

In the past 12 months, Bionano Genomics, Inc. insiders reported 2 open-market purchases worth $10K and 0 sales worth $0.

2Insider buys, 12 months

$10KBought by insiders, 12 months

$0Sold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 9, 2026.

Recent BNGO insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 9	Sep 4	Albert LudererCEO	CEO (ind.)	▲ BUY	4,000	1.21	$5K	+100%	Form 4 ↗
Aug 21	Aug 21	Albert LudererCEO	CEO (ind.)	▲ BUY	4,000	1.22	$5K	New	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Albert Luderer	CEO	2	$10K	0	$0	Sep 9, 2026

Tracked funds that report BNGO

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	51,100	$58K	0.00%	▲ +4.9%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →